The use of polyphenols extracted from Chinese sweet leaf tea (Rubus suavissimus S. Lee.) as novel drugs for the treatment of metabolic dysfunction associated steatotic liver disease

The use of polyphenols extracted from Chinese sweet leaf tea (Rubus suavissimus S. Lee.) as novel drugs for the treatment of metabolic dysfunction associated steatotic liver disease

Abstract Background Metabolic dysfunction associated steatotic liver disease (MASLD) is a pressing global health issue with limited treatment options. Chinese sweet leaf tea (CSLT), rich in polyphenols, shows promise in addressing MASLD due to its anti-inflammatory, obesity-reducing, and metabolic-r...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Pan, Yu Liu, Yixuan Huo, Suren R Sooranna, Lu Chen, Lijun Yin, Zhigang Yan, Danna Huang, Lihe Jiang, Wuwei Wu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Hereditas
Subjects:
Chinese sweet leaf tea
Polyphenols
Medical small molecules
Multifaceted approach
Metabolic dysfunction associated steatotic liver disease
Hypolipidemic effects
Online Access:https://doi.org/10.1186/s41065-025-00504-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s41065-025-00504-6

Similar Items